1265295-16-6

Selexipag-d8 is a labelled version of Selexipag (S253150) which is an orally available, highly selective, long-acting prostacyclin (IP) receptor agonist prodrug. It is a potential drug for the treatment of various vascular disorders such as pulmonary arterial hypertension and arteriosclerosis obliterans.